Fund III

US$ 0 M

our portfolio


AESOP stands for AI-enhanced Safety of Physicians and can make physician clinical documentation easier, faster, and less error-prone using Machine Learning on 3.2 billion patient visits


Powered by AI,addresses unique challenges in cytology slide digitization, image analysis, and workflow optimization.


CUUMED® is established in 2013 as a Taiwan CDMO brand. The main product is the high-end medical catheter.


FaceHeart Corp. improves human health through its proprietary video-based rPPG solutions.

Health 2 Sync (Fund III)

H2Sync aims to provide cloud-based personalized, scalable digital solutions for chronic disease patients to help users improve chronic disease management.

HORIEN Biochemical Technology (Fund III)

HORIEN focuses on developing medical-grade collagen. The mission is to provide cost-effective and high-quality collagen implant products for wound healing and various applications in different medical fields.